Literature DB >> 17526962

Fulminant hepatic failure complicating visceral leishmaniasis in an apparently immunocompetent child.

Arun K Baranwal1, Ravi N Mandal, Rupa Singh.   

Abstract

Fulminant hepatic failure (FHF) is an unusual complication of visceralleishmaniasis (VL). Here, we present a 1.5-yr-old girl with VL developing rapidly progressive fatal FHF. In absence of established guidelines, additional use of immunomodulatory therapies has been discussed in reference to available information.

Entities:  

Mesh：

Year:  2007        PMID： 17526962     DOI： 10.1007/s12098-007-0083-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  14 in total

1.  Fulminant hepatitis in Kala-azar.

Authors:  U K Singh; R K Sinha; V K Sharma
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

Review 2.  Nutrition and the immune system from birth to old age.

Authors:  R K Chandra
Journal:  Eur J Clin Nutr       Date:  2002-08       Impact factor: 4.016

3.  Fulminant hepatitis in an Italian infant with visceral leishmaniasis.

Authors:  L di Martino; P Vajro; A Nocerino; S Scotti; G Napolitano; A Vegnente
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Jan-Feb       Impact factor: 2.184

Review 4.  Treatment of visceral leishmaniasis.

Authors:  Shyam Sundar; Madhukar Rai
Journal:  Expert Opin Pharmacother       Date:  2005-12       Impact factor: 3.889

5.  Amphotericin B-induced hepatorenal failure in cystic fibrosis.

Authors:  Uthara R Mohan; Andrew Bush
Journal:  Pediatr Pulmonol       Date:  2002-06

Review 6.  Tissue granuloma structure-function in experimental visceral leishmaniasis.

Authors:  H W Murray
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

7.  The importance of TGF-beta in murine visceral leishmaniasis.

Authors:  M E Wilson; B M Young; B L Davidson; K A Mente; S E McGowan
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

8.  Differential effects of iron deficiency and underfeeding on serum levels of interleukin-10, interleukin-12p40, and interferon-gamma in mice.

Authors:  Solo Kuvibidila; Raj P Warrier
Journal:  Cytokine       Date:  2004-04-21       Impact factor: 3.861

9.  Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.

Authors:  E M Carvalho; A Barral; D Pedral-Sampaio; M Barral-Netto; R Badaró; H Rocha; W D Johnson
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

10.  Liver morphology and function in visceral leishmaniasis (Kala-azar).

Authors:  I A el Hag; F A Hashim; I A el Toum; M Homeida; M el Kalifa; A M el Hassan
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411
View more
  3 in total

1.  Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice.

Authors:  Suelen S da Silva; Sandra S Mizokami; Jacqueline R Fanti; Milena M Miranda; Natalia Y Kawakami; Fernanda Humel Teixeira; Eduardo J A Araújo; Carolina Panis; Maria A E Watanabe; José M Sforcin; Wander R Pavanelli; Waldiceu A Verri; Ionice Felipe; Ivete Conchon-Costa
Journal:  Parasitol Res       Date:  2015-12-28       Impact factor: 2.289

2.  Acute liver failure due to visceral leishmaniasis in Barcelona: a case report.

Authors:  Iratxe Martinez de Narvajas; Alba Díaz; Octavio Bassegoda; Adriá Carpio; Carla Fuster; María Eugenia Valls; Miriam J Alvarez-Martínez; Carolina García-Vidal; Alejandro Soriano; José Antonio Martínez; Juan Ambrosioni
Journal:  BMC Infect Dis       Date:  2019-10-22       Impact factor: 3.090

3.  Severe visceral leishmaniasis and COVID-19 coinfection in an immunosuppressed patient.

Authors:  Luciamáre Perinetti Alves Martins; Josianne Thomazini Fukasawa; Mirella Beni Balbino Ferreira Messias; Roberto Esteves Pires Castanho; Leticia Abrantes Andrade; Márcia Aparecida Sperança; Rodrigo Buzinaro Suzuki
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-03-11       Impact factor: 1.846
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.